Jove
Visualize
Contact Us

Related Experiment Videos

Nonfatal methazolamide-induced aplastic anemia.

J L Gangitano, S H Foster, R M Contro

    American Journal of Ophthalmology
    |July 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Methazolamide can cause aplastic anemia, a serious condition where the body stops producing enough blood cells. Early diagnosis and treatment, including medication withdrawal and transfusions, are crucial for recovery.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Antagonism of leukotriene receptors and administration of a 5-lipoxygenase inhibitor do not affect hypoxic vasoconstriction.

    Lung·1989
    Same author

    Effectiveness of language intervention with the language/learning disabled.

    The Journal of speech and hearing disorders·1987
    Same author

    Cyclooxygenase inhibition and improved oxygenation in patients with pulmonary complications of AIDS.

    New York state journal of medicine·1987
    Same author

    Learning discourse topic management in the preschool years.

    Journal of child language·1986
    Same author

    Bilateral Toxocara optic neuropathy.

    Journal of clinical neuro-ophthalmology·1983
    Same author

    Fibroma in a Nine-banded armadillo (Dasypus novemcinctus).

    Journal of comparative pathology·1983
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Hematology
    • Pharmacology

    Background:

    • Aplastic anemia is a rare but serious condition.
    • Methazolamide is a carbonic anhydrase inhibitor used to treat glaucoma and epilepsy.

    Observation:

    • An 83-year-old male patient developed nonfatal aplastic anemia.
    • The patient had been taking methazolamide for three months prior to diagnosis.

    Findings:

    • Methazolamide-induced aplastic anemia was diagnosed.
    • Treatment included medication cessation, blood product transfusions, and oxymetholone therapy.

    Implications:

    • This case highlights a potential adverse effect of methazolamide.
    • Prompt diagnosis and management are essential for patient outcomes in drug-induced aplastic anemia.